News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,428 Results
Type
Article (76574)
Company Profile (720)
Press Release (774105)
Multimedia
Podcasts (223)
Webinars (35)
Section
Business (228149)
Career Advice (3752)
Deals (39514)
Drug Delivery (175)
Drug Development (89951)
Employer Resources (207)
FDA (18275)
Job Trends (17273)
News (389591)
Policy (39010)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3046)
Academic (1)
Accelerated approval (52)
Adcomms (40)
Allergies (185)
Alliances (56074)
ALS (226)
Alzheimer's disease (1950)
Antibody-drug conjugate (ADC) (520)
Approvals (18589)
Artificial intelligence (782)
Autoimmune disease (328)
Automation (60)
Bankruptcy (405)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (438)
Bladder cancer (207)
Brain cancer (83)
Breast cancer (807)
Cancer (6264)
Cardiovascular disease (536)
Career advice (3228)
Career pathing (50)
CAR-T (367)
CDC (75)
Celiac Disease (3)
Cell therapy (1011)
Cervical cancer (49)
Clinical research (77322)
Collaboration (2290)
Company closure (7)
Compensation (1460)
Complete response letters (103)
COVID-19 (3032)
CRISPR (120)
C-suite (1231)
Cystic fibrosis (164)
Data (8257)
Decentralized trials (3)
Denatured (84)
Depression (187)
Dermatology (92)
Diabetes (633)
Diagnostics (7522)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (371)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (308)
Earnings (99569)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (136759)
Executive appointments (1170)
FDA (22208)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1867)
Gene editing (263)
Generative AI (75)
Gene therapy (824)
GLP-1 (1253)
Government (5496)
Grass and pollen (8)
Guidances (413)
Healthcare (21103)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (348)
Immuno-oncology (106)
Indications (197)
Infectious disease (3411)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (302)
Interviews (734)
IPO (17913)
IRA (61)
Job creations (5002)
Job search strategy (2603)
JPM (73)
Kidney cancer (21)
Labor market (115)
Layoffs (677)
Leadership (51)
Legal (9967)
Liver cancer (108)
Longevity (34)
Lung cancer (824)
Lymphoma (443)
Machine learning (63)
Management (66)
Manufacturing (1157)
MASH (211)
Medical device (15222)
Medtech (15357)
Mergers & acquisitions (22869)
Metabolic disorders (1706)
mRNA (255)
Multiple sclerosis (199)
NASH (24)
Neurodegenerative disease (480)
Neuropsychiatric disorders (125)
Neuroscience (3616)
Neurotech (1)
NextGen: Class of 2026 (7662)
Non-profit (5137)
Now hiring (79)
Obesity (829)
Opinion (369)
Ovarian cancer (234)
Pain (280)
Pancreatic cancer (325)
Parkinson's disease (394)
Partnered (36)
Patents (627)
Patient recruitment (712)
Peanut (67)
People (66565)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23934)
Phase 2 (33742)
Phase 3 (25377)
Pipeline (9191)
Policy (390)
Postmarket research (3261)
Preclinical (10564)
Press Release (72)
Prostate cancer (325)
Psychedelics (68)
Radiopharmaceuticals (357)
Rare diseases (1217)
Real estate (7205)
Recruiting (81)
Regulatory (29441)
Reports (75)
Research institute (2757)
Resumes & cover letters (583)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (193)
Series A (316)
Series B (229)
Service/supplier (25)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (188)
Sponsored (55)
Startups (4271)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (136)
Vaccines (1273)
Venture capital (126)
Weight loss (571)
Women's health (134)
Worklife (24)
Date
Today (44)
Last 7 days (708)
Last 30 days (3482)
Last 365 days (32401)
2026 (14083)
2025 (32540)
2024 (37884)
2023 (42563)
2022 (53926)
2021 (58720)
2020 (57661)
2019 (51300)
2018 (39079)
2017 (36827)
2016 (37733)
2015 (43724)
2014 (38361)
2013 (34352)
2012 (36247)
2011 (36361)
2010 (35764)
Location
Africa (1215)
Alabama (102)
Alaska (7)
Arizona (372)
Arkansas (16)
Asia (50448)
Australia (8655)
California (13969)
Canada (3898)
China (1478)
Colorado (599)
Connecticut (613)
Delaware (428)
Europe (114998)
Florida (2074)
Georgia (456)
Hawaii (4)
Idaho (68)
Illinois (1164)
India (98)
Indiana (644)
Iowa (25)
Japan (562)
Kansas (140)
Kentucky (56)
Louisiana (48)
Maine (89)
Maryland (1696)
Massachusetts (10180)
Michigan (405)
Minnesota (779)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (150)
New Hampshire (91)
New Jersey (3711)
New Mexico (34)
New York (3658)
North Carolina (1883)
North Dakota (11)
Northern California (6925)
Ohio (430)
Oklahoma (26)
Oregon (53)
Pennsylvania (2768)
Puerto Rico (30)
Rhode Island (53)
South America (1578)
South Carolina (88)
South Dakota (2)
Southern California (5475)
Tennessee (221)
Texas (2249)
United States (49861)
Utah (417)
Vermont (1)
Virginia (356)
Washington D.C. (88)
Washington State (1142)
West Virginia (4)
Wisconsin (153)
Wyoming (2)
851,428 Results for "torii pharmaceutical co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
February 9, 2026
·
5 min read
Press Releases
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum
September 22, 2025
·
5 min read
Business
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Verrica Pharmaceuticals Inc. today announced that it has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. (Torii), to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH® for the treatment of common warts.
May 15, 2024
·
9 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
July 2, 2025
·
8 min read
Drug Development
Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan
Verrica Pharmaceuticals Inc. announced that its development and commercialization partner, Torii Pharmaceutical Co., Ltd., reported positive top-line results from its Phase 3 trial of TO-208 for the treatment of Molluscum Contagiosum in Japan.
December 15, 2023
·
4 min read
Press Releases
Model Medicines to Present Evidence of First Direct-Acting Antiviral Potent Against HCV, HBV, HDV, and Co-Infections at CROI 2026
Over 300 million patients are infected with HCV, HBV, HDV, and their co-infections. MDL-001 is the first oral small molecule to demonstrate potent, direct-acting antiviral activity across all three viruses and their co-infections.
February 18, 2026
·
1 min read
Press Releases
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
April 14, 2026
·
1 min read
Press Releases
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
December 9, 2024
·
5 min read
Press Releases
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
May 19, 2026
·
5 min read
1 of 85,143
Next
